Pharma channel feed

San­doz plans to stay lo­cal af­ter No­var­tis sep­a­ra­tion, se­lect­ing new HQ in Basel

Last year
People

Am­gen cen­ters can­cer pa­tients’ voic­es in new YouTube se­ries

Last year
Marketing

Vi­a­tris tar­gets ul­cer­a­tive col­i­tis in Japan with $10M agree­ment with Swedish phar­ma In­Dex

Last year

CMS makes it of­fi­cial: Cov­er­age for new Alzheimer's drugs once full ap­provals ar­rive

Last year

Mark Cuban read­ies to fight Hu­mi­ra's megablock­buster fran­chise next month

Last year

FDA ap­proves Pfiz­er’s RSV shot for old­er adults, tee­ing up a com­pet­i­tive $17B vac­cine mar­ket

Last year
FDA+

FDA's can­cer chief weighs in on com­mon chemo short­ages — re­port

Last year
FDA+
Manufacturing

NICE rec­om­mends Pfiz­er's mi­graine drug for use in the UK, with some re­stric­tions

Last year

Yuhan Cor­po­ra­tion to pay $325M to in-li­cense pre­clin­i­cal HER2 can­di­date

Last year
Deals

Can­cer as­so­ci­a­tion says na­tion­al bud­get deal threat­ens re­search fund­ing

Last year

FDA warns about com­pound­ed semaglu­tide-based drugs

Last year
FDA+
Manufacturing

PBM as­so­ci­a­tion launch­es ad cam­paign push­ing back on drug­mak­er­s' lob­by­ing ‘pow­er’ amid con­gres­sion­al pres­sure

Last year
Marketing

Sanofi rolls out PhII mul­ti­ple scle­ro­sis da­ta that will take the phar­ma in­to piv­otal stud­ies next year

Last year
R&D

Al­ny­lam files a new set of law­suits against Mod­er­na and Pfiz­er over Covid-19 vac­cines

Last year
Law

Eli Lil­ly set­tles in­sulin pric­ing law­suit for $13.5M, month­ly out-of-pock­et com­mit­ment

Last year
FDA+

Clar­i­ty want­ed: When can new drug price ne­go­ti­a­tions be chal­lenged in court?

Last year
Law

Emer­gent to de­liv­er a $120M con­tract for the small­pox vac­cine for the US stock­pile

Last year
Manufacturing

Mar­ket­ingRx roundup: Bio­gen be­gins so­cial aware­ness around post­par­tum de­pres­sion; Phar­ma mar­keters in the NBA games

Last year
Marketing

Vi­a­tris re-ups med­ical ed­u­ca­tion spon­sor­ship pledge, adds health eq­ui­ty to pri­ma­ry care train­ing

Last year
Marketing

EU com­mit­tee like­ly to rec­om­mend against ap­prov­ing Amy­lyx ALS drug, com­pa­ny says

Last year
R&D
FDA+

FDA ap­proves Lex­i­con’s heart-fail­ure drug af­ter de­feat in di­a­betes

Last year
FDA+

Astel­las, Seagen add fire­fight­er mes­sag­ing in blad­der can­cer aware­ness cam­paign

Last year
Marketing

Genen­tech spon­sors fash­ion-for­ward mod­els walk­ing and rolling the run­way again in SMA en­core show

Last year
Marketing

Eu­ro­pean Com­mis­sion to re­ceive few­er Pfiz­er-BioN­Tech vac­cine dos­es un­der amend­ed con­tract

Last year
Coronavirus
First page Previous page 119120121122123124125 Next page Last page
A service from the Financial Times